Assignee
INTROGEN THERAPEUTICS INC
US·7 granted patents·17 pending applications·643 citations·filing 1997–2009
Top patents by PatentIndex Score
24 records- 0196US7125706B2Method for the production and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2001·Granted Oct 24, 2006·89 cites·20 claims
- 0296US6726907B1Purified adenoviral compositionsINTROGEN THERAPEUTICS INC·Filed 2000·Granted Apr 27, 2004·94 cites·35 claims
- 0396US6194191B1Method for the production and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 1997·Granted Feb 27, 2001·299 cites·89 claims
- 0495US6689600B1Formulation of adenovirus for gene therapyINTROGEN THERAPEUTICS INC·Filed 1999·Granted Feb 10, 2004·70 cites·59 claims
- 0594US7445930B2Method for the production and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2004·Granted Nov 4, 2008·55 cites·29 claims
- 0694US7235391B2Formulation of adenovirus for gene therapyINTROGEN THERAPEUTICS INC·Filed 2001·Granted Jun 26, 2007·31 cites·20 claims
- 0781US7419808B2Methods and compositions for the production of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2005·Granted Sep 2, 2008·5 cites·62 claims
- 0861US2007155008A1Method for the production and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0958US2008050770A1Method for the production and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1057US2006275781A1Novel method for the protection and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1154US2007231304A1Prognostic factors for anti-hyperproliferative disease gene therapyINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1252US2003224354A1Quantifying viral particles with intrinsic fluorescenceINTROGEN THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1351US2006052322A1Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agentINTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1451US2009253184A1Compositions and methods related to an adenoviral trans-complementing cell lineINTROGEN THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1549US2007281041A1Compositions and Methods Involving MDA-7 for the Treatment of CancerINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1648US2004229335A1Methods and compositions for the production of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1746US2007172846A1Methods for the Production and Purification of Adenoviral VectorsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1844US2010209451A1Compositions and Methods Related to Adenovirus Based Delivery of AntigensINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1944US2006153808A1Cancer immunotherapy incorporating p53INTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2044US2008044378A1Methods and Compositions for Protein Production Using Adenoviral VectorsINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2142US2007066552A1Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acidsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2241US2006134801A1Methods and compositions involving MDA-7INTROGEN THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2341US2008293652A1Combination of Ad-P53 and Chemotherapy for the Treatment of TumoursINTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2439US2004106184A1Chromatographic methods for adenovirus purificationINTROGEN THERAPEUTICS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INTROGEN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →